Dr. Miles Murphy, M.D.
Urogynecology (Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician)
- Medicare participating
At a glance
- Medical school
- University of Pittsburgh School of Medicine (1997)
- Years since graduation
- 29
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 349
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1997Medical school: University of Pittsburgh School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician primary
PA license MD071109L
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- St Lukes Hospital Bethlehem, PA
- St Luke's Hospital - Upper Bucks Campus Quakertown, PA
- Doylestown Hospital Doylestown, PA
- Jefferson Abington Hospital Abington, PA
- Jefferson Lansdale Hospital Lansdale, PA
Medical groups
- Regional Womens Health Group LLC (354 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 349
- Services billed
- 1,819
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Ultrasound measurement of bladder capacity after voiding | 151 | 148 |
| Electronic assessment of bladder emptying | 141 | 116 |
| Established patient office or other outpatient visit, 30-39 minutes | 113 | 95 |
| Established patient office or other outpatient visit, 40-54 minutes | 111 | 101 |
| New patient office or other outpatient visit, 45-59 minutes | 78 | 78 |
| Established patient office or other outpatient visit, 20-29 minutes | 70 | 58 |
| Simple bladder irrigation and/or instillation | 64 | 40 |
| Urinalysis, manual test | 61 | 48 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 60 | 33 |
| New patient office or other outpatient visit, 60-74 minutes | 58 | 58 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Myrbetriq (mirabegron) Other prescribers in Allentown, PA | 275 |
| Nitrofurantoin Mono-Macro (nitrofurantoin monohyd/m-cryst) Other prescribers in Allentown, PA | 230 |
| Solifenacin Succinate Other prescribers in Allentown, PA | 186 |
| Estradiol Other prescribers in Allentown, PA | 113 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Allentown, PA | 111 |
| Gemtesa (vibegron) Other prescribers in Allentown, PA | 109 |
| Methenamine Hippurate Other prescribers in Allentown, PA | 99 |
| Ciprofloxacin Hcl Other prescribers in Allentown, PA | 67 |
| Amitriptyline Hcl Other prescribers in Allentown, PA | 39 |
| Oxybutynin Chloride Er (oxybutynin chloride) Other prescribers in Allentown, PA | 39 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 64 payments worth $3,371 in total to this clinician.
| Medtronic, Inc. | $911 |
|---|---|
| Teleflex LLC | $700 |
| Coloplast Corp | $595 |
| AbbVie Inc. | $410 |
| Astellas Pharma US Inc | $311 |
| Femselect Inc. | $104 |
| Caldera Medical, Inc | $102 |
| Sumitomo Pharma America, Inc. | $95.47 |
| Food and Beverage | $1,707 |
|---|---|
| Travel and Lodging | $865 |
| Honoraria | $700 |
| Education | $99.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Medtronic, Inc. Nov 7, 2025 | Travel and Lodging ALTAVIVA · Tibial Nerve Stimulation · travel to Charlotte, NC · in-kind | $364 |
| Teleflex LLC Dec 19, 2025 | Honoraria BARRIGEL · INTERVENTIONAL UROLOGY | $350 |
| Teleflex LLC May 9, 2025 | Honoraria BARRIGEL · INTERVENTIONAL UROLOGY | $350 |
| Medtronic, Inc. Dec 4, 2025 | Travel and Lodging ALTAVIVA · Tibial Nerve Stimulation · travel to Baltimore, MD · in-kind | $289 |
| Astellas Pharma US Inc Oct 21, 2025 | Education in-kind | $99.00 |
| Medtronic, Inc. Nov 7, 2025 | Travel and Lodging ALTAVIVA · Tibial Nerve Stimulation · travel to Charlotte, NC · in-kind | $56.32 |
| Medtronic, Inc. Dec 11, 2025 | Travel and Lodging ALTAVIVA · Tibial Nerve Stimulation · travel to Charlotte, NC · in-kind | $48.82 |
| Medtronic, Inc. Dec 4, 2025 | Travel and Lodging ALTAVIVA · Tibial Nerve Stimulation · travel to Baltimore, MD · in-kind | $44.07 |
| Medtronic, Inc. Dec 11, 2025 | Travel and Lodging ALTAVIVA · Tibial Nerve Stimulation · travel to Charlotte, NC · in-kind | $31.30 |
| Medtronic, Inc. Dec 11, 2025 | Travel and Lodging ALTAVIVA · Tibial Nerve Stimulation · travel to Charlotte, NC · in-kind | $31.30 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 2 companies. The companies reported $36,688 in research payments for these studies, mostly to the institutions running them.
- A long term prospective Post Market Clinical Follow-up (PMCF) of the GYNECARE TVT ABBREVO Continence System for the treatment of Stress Urinary Incontinence.
Ethicon Inc. - PVP-22IC04
Provepharm Inc. - A retrospective and long-term prospective post market clinical follow-up (PMCF) of the GYNECARE GYNEMESH PS Nonabsorbable PROLENE Soft Mesh
Ethicon Inc. - A long term prospective Post Market Clinical Follow-up (PMCF) of the GYNECARE TVT EXACT Continence System for the treatment of Stress Urinary Incontinence.
Ethicon Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.